A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer.
In this Science Surgery post we explore the work being done to use existing treatments in other types of cancer.
Our new research partnership is exploring common ground between arthritis and cancer, which could bring benefits to patients on both sides.
We spoke to Professor Margaret Frame, from the Cancer Research UK Edinburgh Centre, about her OBE for her contribution to cancer research.
Infecting tumours with viruses may boost the success of immunotherapy for brain and breast cancers, according to two new studies.
Four in 10 patients with aggressive lymphoma were cancer-free 15 months after treatment with engineered immune cells, according to new clinical trial results.
Combining two different immunotherapy treatments could dramatically improve lymphoma survival.
Find out the burning questions some of our researchers want to answer as they set up their own research teams for the first time.
This week saw new research on brain tumour and ovarian cancers, while MPs launched an inquiry into e-cigarettes.
A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease.